Pathology
 |
|
12 february 2020 21:00:17 |
| Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI (Prostate Cancer and Prostatic Diseases) |
|
Tweet |
| 190 viewsCategory: Oncology, Pathology |
 Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis (Prostate Cancer and Prostatic Diseases)Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer (Prostate Cancer and Prostatic Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
